Ticker Symbol: UBX
Unity Biotechnology Inc
$2.70 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001463361
Company Profile
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 3280 Bayshore Blvd
Website: unitybiotechnology.com
CEO: Anirvan Ghosh
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.98
Change:
-$0.10
(
-4.81%)
Days Range: $1.98 - $2.12
Beta: 1.51
52wk. High: $5.72
52wk. Low: $1.46
Ytd. Change -28.90%
50 Day Moving Average: $2.22
200 Day Moving Average: $2.58
Shares Outstanding: 14601258
Valuation
Market Cap: 2.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A